Only then can pharmaceutical manufacturers pinpoint potential compliance risks and bottlenecks ... against chikungunya approved for use in the US, after Bavarian Nordic gets the green light ...
U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...
U.S. FDA classifies Aurobindo Pharma warehouse in New Jersey as Official Action Indicated, impacting compliance and ...
Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...
Hosted on MSN16d
Virpax Pharmaceuticals director resigns due to complianceSimultaneously, Virpax Pharmaceuticals was granted an extension by the Nasdaq Hearings Panel to maintain its listing status, with a compliance deadline set for April 1, 2025. The company also made ...
In the backdrop of the US-India dialogue on tariffs, the Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian ...
Subsequently, the US FDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated (OAI)'.
Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback